Estimating the cost-effectiveness of belimumab versus standard care for sle patients in Hong Kong
May 1, 2013, 00:00
10.1016/j.jval.2013.03.564
https://www.valueinhealthjournal.com/article/S1098-3015(13)00635-9/fulltext
Title :
Estimating the cost-effectiveness of belimumab versus standard care for sle patients in Hong Kong
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00635-9&doi=10.1016/j.jval.2013.03.564
First page :
A117
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
103